• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2015 Fiscal Year Final Research Report

Analysis of the molecular mechanism and clinical targets for neural tumors via the loss of function of NF1/NF2 gene products

Research Project

  • PDF
Project/Area Number 25293312
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypePartial Multi-year Fund
Section一般
Research Field Neurosurgery
Research InstitutionKumamoto University

Principal Investigator

Araki Norie  熊本大学, 大学院生命科学研究部(医), 准教授 (80253722)

Co-Investigator(Kenkyū-buntansha) KURATSU Junichi  熊本大学, 大学院生命科学研究部, 教授 (20145296)
NAKAMURA Hideo  熊本大学, 付属病院, 講師 (30359963)
Project Period (FY) 2013-04-01 – 2016-03-31
Keywordsneurofibromatosis / NF1 / proteomics / mTOR / TCTP
Outline of Final Research Achievements

Neurofibromatosis type 1/2 (NF1/2) is an autosomal dominant disease that predisposes individuals to develop neural tumors including neurofibromas and malignant tumors etc. To identify novel biological targets for NF-associated tumors, a unique integrated-omics was performed, and a novel abnormal network, “Translationally controlled tumor protein (TCTP)-mTOR/EF signalings” was identified. This network activates the MAPK/PI3K-AKT-mTOR and specific EF1 complex associated translational signalings in NF1 tumors. In NF1-deficient MPNST cells, MAPK/PI3K/mTOR inhibitors downregulated TCTP associated cell expansions, and TCTP knockdown (or overexpression) suppressed (or activated) mTOR/EF1 signalings. Artesunate, a TCTP target, inhibited the TCTP-mTOR/EF1 signal cascade and suppressed the viability of MPNST cells significantly. These findings suggest that TCTP-mTOR/EF signaling is implicated in the progression of NF1-tumors and could serve as a biological target for the specific therapy.

Free Research Field

腫瘍生化学

URL: 

Published: 2017-05-10  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi